Diagnostics

A new ARPA-H grant aims to replace 50-year-old tech with a rapid blood test for fetal hypoxia, a move that could slash C-sections and save lives.

A new animal-free ingredient from Proliant Health & Biologicals aims to solve major regulatory, ethical, and performance challenges in the life sciences.

S&G Labs just launched a veteran scholarship. It’s more than PR—it’s a blueprint for how mission-driven companies are redefining impact in 2026.

Facing delisting, Virax Biolabs consolidates its shares in a bid to survive. This move buys time, but the real test lies in its innovative T-cell technology.

A groundbreaking study in Nature Water reveals wastewater analysis can detect fentanyl trends 15 months ahead of traditional data, offering a powerful new tool.

Following a $30M funding round, Mammogen appoints Dr. Elise Berman as CMO to spearhead its genTRU-breast™ test, aiming to solve the dense breast dilemma.

The Brain Aneurysm Foundation partners with a tech advocacy group to highlight AI's life-saving potential in spotting deadly aneurysms before they rupture.

A new law makes Illinois a pioneer, mandating Medicaid coverage for predictive blood tests. Can this tech-driven policy shift the tide on maternal health?

Dynacare's new at-home hormone tests promise unprecedented access and privacy. But are Canadians ready to navigate their health data outside the clinic?

Pathway Labs' FDA-cleared AI, EchoNext, detects hidden heart disease. A key partnership and $8.5M seed round signal a major shift for MedTech investors.

A new NYC startup, Yunara Life, is betting it can solve healthcare's engagement crisis by letting users earn aesthetic rewards for healthy habits. Is this a brilliant hack or a concerning trend?

An EY award for Rhythm Express founders highlights a deeper story of strategic innovation, patient-centric design, and the future of remote health monitoring.

A pivotal NCCN guideline update for bladder cancer validates Natera's Signatera test, ushering in a new era of personalized, MRD-guided cancer treatment.

Spotlight Medical's myStage Dx secures tough IVDR CE mark, using AI on standard lab slides to help doctors pinpoint which patients can safely avoid chemo.

The diagnostics firm is launching a monthly webinar series, an unusual move that blends investor relations with direct-to-consumer marketing. Is this the new playbook?

A $100k grant will help hospitals decide between local and send-out DNA testing for transplant monitoring, a move that could reshape patient care and markets.

Digital health innovator Light AI has secured C$5M to navigate the regulatory maze. Can its AI platform truly revolutionize diagnostics from our pockets?

For decades, insomnia treatment meant risky sedatives. Now, a new class of drugs is revolutionizing sleep science, promising safer rest for millions.

Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British Columbia's status as a global hub for health innovation.

A new study of 100M insurance claims reveals a shocking failure: nearly 9 in 10 women in some states get no osteoporosis care after a fracture. Why?